The Chief Scientific Adviser, who is leading the Government’s expert panel on vaccines, has 43,111 shares in GlaxoSmithKline (GSK) from his time as president of the drugs company. This is the company the UK government has contracted to make the vaccine. The Government has denied arguments that this is a potential conflict of interest, asserting that he is not involved in commercial decisions on coronavirus vaccines.
